3 Patents
- US125044312025Biomarkers for a Therapy Comprising a Sorafenib Compound
Eisai R&D Management Co., Ltd.
0 cites - 0 cites
- US115987762023Biomarkers for Predicting and Assessing Responsiveness of Thyroid and Kidney Cancer Subjects to Lenvatinib Compounds
Eisai R&D Management Co., Ltd.
0 cites